Helen Floersh

Staff Reporter (Retail, Nonprofits)

Helen covers retail, hospitality and nonprofits in the greater Valley region.

Email: hfloersh@sfvbj.com
Phone: 818-316-3121 Extension: 112

Recent Stories

Woodbury Names Local Business Leader to Board

Woodbury University in Burbank has named Greg Lippe, an accountant based in Simi Valley, to serve as chairman of its board of trustees.

Pixar Exec Takes Leave for ‘Missteps’

John Lasseter, creative head of Walt Disney Co.’s Pixar Inc. and Walt Disney Animation Studios, will take a leave of absence from the company following allegations of inappropriate conduct in the workplace.

Amgen Invests in Software Startup Syapse

Amgen Ventures, the investment arm of Thousand Oaks biopharmaceutical firm Amgen Inc., has invested an undisclosed sum in Syapse Inc., a San Francisco software company that has developed an integrative platform designed to streamline the “precision medicine” approach to cancer treatment.

Lancaster City Council Supports Water Rate Reform

The Lancaster City Council has put its stamp of approval on the efforts of a grassroots campaign that seeks to reform the way rates are set by private water companies.

Amgen to Lay Off 121

Amgen Inc. will lay off up to 121 workers at its California sites beginning Dec. 31, according to a notice filed in early November with the California Employment Development Department.

Tease photo

Union Holds Protest in Warner Center

Workers and supporters of the local operating engineers union made themselves heard Monday morning during a protest at the Warner Center in Woodland Hills.

Simi Group Revives the Renaissance

Folk with 14th century interests gather for weekend event.

Businesses with medieval flair show their wares at Renaissance faire.

Legal Diplomats

Law firms need managers with special people skills, say authors Andrew Elowitt and Marcia Watson Wasserman.

Q&A: Lawyer manager Marcia Watson Wasserman and attorney Andrew Elowitt on how to manage law firms

Amgen, Novartis Launch Alzheimer’s Drug Trial

PHARMA: Treatment could prevent symptoms, but prior therapies have failed.

Amgen Inc. and Swiss biopharma Novartis have launched a second clinical trial for their co-developed drug to prevent or delay the onset of Alzheimer’s disease in high-risk patients who are not yet showing symptoms.

50 Fastest Growing Private Companies 2017: Geolinks

Building Broadband Access for Rural America

Largest Company and Star Performer winners.

More stories >>